Matches in Nanopublications for { ?s ?p "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP875414.RAQHn-b5rNrtTJeLbdEqP1qk3YHRKJ1o31jrkaoo1oNBE130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875414.RAQHn-b5rNrtTJeLbdEqP1qk3YHRKJ1o31jrkaoo1oNBE130_provenance.
- NP488248.RAosFhE7hQMOheCjkXAy3Tw5kO2_LbaONNqfJPzj7pzKc130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP488248.RAosFhE7hQMOheCjkXAy3Tw5kO2_LbaONNqfJPzj7pzKc130_provenance.
- NP209271.RAu5I0Apsxj-etUuo56xlR6cmrr7Mh0ewzJ1KZhq5PBhM130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209271.RAu5I0Apsxj-etUuo56xlR6cmrr7Mh0ewzJ1KZhq5PBhM130_provenance.
- NP216169.RAUq3edY0RDRJaD-HjDnSWrryUB74oiUZlFiWopebMtuE130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP216169.RAUq3edY0RDRJaD-HjDnSWrryUB74oiUZlFiWopebMtuE130_provenance.
- NP406486.RAYGNpRCwfpanCCvSzURZgqf2Jc-J7HHY4rUcDdaoqPy8130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406486.RAYGNpRCwfpanCCvSzURZgqf2Jc-J7HHY4rUcDdaoqPy8130_provenance.
- NP944820.RA9144ehVrcuqlymJFxObeYCUiMjAieF7ImMrB_UHqanE130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP944820.RA9144ehVrcuqlymJFxObeYCUiMjAieF7ImMrB_UHqanE130_provenance.
- NP1011745.RAw2D7mzDl8z_Av4c5NIT6ic12GICkOZrDpnkenGDPCNQ130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1011745.RAw2D7mzDl8z_Av4c5NIT6ic12GICkOZrDpnkenGDPCNQ130_provenance.
- NP976631.RA7DNiJ9A5HUWD1s22eiB6MebAQoQvF2I7qSG_h3vnDU4130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976631.RA7DNiJ9A5HUWD1s22eiB6MebAQoQvF2I7qSG_h3vnDU4130_provenance.
- NP727266.RALPAtEx2dmn5_g8uguG0epZ72BCuCInYZiHHxRNxJbFA130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727266.RALPAtEx2dmn5_g8uguG0epZ72BCuCInYZiHHxRNxJbFA130_provenance.
- NP976633.RAJ51D9HzSPiFYFiC0tAzlPgS8-xh5sUhn7uMZGfE1ow8130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976633.RAJ51D9HzSPiFYFiC0tAzlPgS8-xh5sUhn7uMZGfE1ow8130_provenance.
- NP787872.RAgh_unu8o2A7RV27wEVn-vYf38u5WojjQSf-ADTwE-K0130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787872.RAgh_unu8o2A7RV27wEVn-vYf38u5WojjQSf-ADTwE-K0130_provenance.
- NP976630.RAsAHcDPt7hdkW2fFryoKu5u9mSDj8r8GjV5EJLcsYeDc130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976630.RAsAHcDPt7hdkW2fFryoKu5u9mSDj8r8GjV5EJLcsYeDc130_provenance.
- NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_assertion description "[These findings suggest that CXCR7 is a novel TEC marker and a target for antiangiogenic therapy for RCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976632.RAmsAhgp1lEALrxHxGgjd2YIcl3n6WRLwtR72NY3o0vPc130_provenance.